Oncology Tube
@oncologytube
Produce, Find, and Distribute the latest and highest quality multimedia to oncologists, hematologists and researchers.
ID: 78745126
http://www.oncologytube.com 30-09-2009 23:55:07
140,140K Tweet
16,16K Takipçi
796 Takip Edilen
FDA Approved #Lazcluze #Rybrevant Combo in Advanced #NSCLC: Data Revealed to Oncologists The ASCO Post JanssenUS Johnson & Johnson #MARIPOSA #EGFR
Nivolumab Combo Phase 3 TiNivo 2 Results + Tivozanib in RCC Presented at ESMO 2024 AVEO Oncology #ESMO2024 Dana-Farber
Nivolumab Combo Phase 3 TiNivo 2 Results + Tivozanib in RCC Presented at ESMO 2024 by Toni Choueiri oncologytube.com/nivolumab-comb… AVEO Oncology #ESMO24 Dana-Farber
WATCH: FDA Approves Durvalumab / IMFINZI® for Resectable #NSCLC Non-Small Cell Lung Cancer AstraZeneca AEGEAN trial FDA Oncology
#ESMO24 2024: TIGIT Combo Delivers Significant Improvement in Lung Cancer Treatment #GSK iTeos Therapeutics #lungcancer #PD1Inhibitors #TIGITTherapy #NSCLC #Immunotherapy #Belrestotug #Dostarlimab #GALAXIESLung301
VIDEO & SLIDES: FDA Approves Kisqali / Ribociclib for Early High-Risk Breast Cancer #ESMO24 oncologytube.com/slides-fda-app… FDA Oncology Novartis Breast Cancer Now @CancerResrchUK American Cancer Society OncoAlert Novartis News #Kisqali #Ribociclib #BreastCancer #FDAApproval #CancerResearch
VIDEO: FDA approves KEYTRUDA® / Pembrolizumab with Chemotherapy for Unresectable Advanced or Metastatic Malignant Pleural Mesothelioma oncologytube.com/fda-approves-k… Adam Merkley FDA Oncology #Immunotherapy #LungCancer #Oncology